Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04517747
Title Ramucirumab Plus TAS-102 in Patients With Advanced or Metastatic Gastric Adenocarcinoma or the Gastroesophageal Junction (RE-ExPEL)
Acronym RE-ExPEL
Recruitment Completed
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Institute for Clinical Cancer Research Krankenhaus Nordwest Frankfurt 60488 Germany Details
Hamburg Hämatologisch-Onkologische Praxis Eppendorf-Facharztzentrum Eppendorf Hamburg 20246 Germany Details
Tagestherapiezentrum am ITM Universitätsmedizin Mannheim Mannheim 68167 Germany Details
Technische Universität München Klinikum Rechts der Isar Muenchen 81675 Germany Details
Universitätsklinikum Ulm Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field